Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,378,185
Closed -$79.1M 2426
2025
Q3
$79.1M Sell
5,378,185
-15,410,178
-74% -$157M 0.04% 317
2025
Q2
$204M Buy
20,788,363
+325,458
+2% +$2.69M 0.1% 186
2025
Q1
$165M Buy
20,462,905
+3,948,849
+24% +$34.5M 0.09% 201
2024
Q4
$129M Buy
16,514,056
+1,355,838
+9% +$11.2M 0.07% 249
2024
Q3
$112M Buy
15,158,218
+1,882,108
+14% +$15.8M 0.06% 262
2024
Q2
$106M Buy
13,276,110
+672,728
+5% +$6.01M 0.06% 254
2024
Q1
$147M Buy
12,603,382
+3,688,241
+41% +$40.8M 0.08% 220
2023
Q4
$99.6M Buy
8,915,141
+4,885,938
+121% +$44.9M 0.06% 252
2023
Q3
$62.2M Sell
4,029,203
-90,715
-2% -$1.52M 0.04% 322
2023
Q2
$78M Buy
4,119,918
+373,880
+10% +$6.57M 0.05% 296
2023
Q1
$57.1M Buy
3,746,038
+2,726,659
+267% +$35.6M 0.04% 355
2022
Q4
$13M Buy
1,019,379
+231,387
+29% +$2.08M 0.01% 660
2022
Q3
$4.56M Sell
787,992
-902,148
-53% -$3.96M ﹤0.01% 843
2022
Q2
$5.45M Buy
+1,690,140
New +$5.1M ﹤0.01% 823
2020
Q4
Sell
-60,650
Closed -$1.56M 1397
2020
Q3
$1.56M Buy
+60,650
New +$1.92M ﹤0.01% 1097

Other funds holding ETNB

Janus Henderson Group's ETNB Position: Q4 2025 in Review

Janus Henderson Group sold out of 89bio (ETNB) in Q4 2025, closing a stake of 5,378,185 shares — an estimated $79.1M sold.

Janus Henderson Group first reported a position in ETNB in Q3 2020 and held it in 15 quarters. The position peaked at $204M in Q2 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Janus Henderson Group reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Janus Henderson Group sold 5,378,185 89bio shares in Q4 2025, an estimated $79.1M.
  • Janus Henderson Group first reported a position in 89bio in Q3 2020 and held it in 15 quarters.
  • Janus Henderson Group's 89bio position peaked at $204M in Q2 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Janus Henderson Group's 13F filing for Q4 2025, filed 17 Feb 2026.